Likewise, high density of TIL (CD3+, CD8+, and CD45RO+ memory) within TME was associated with a good response in patients with colon cancer and melanoma treated with anti-PD-1 or PD-L1 therapies [74,75,76]. This evidence concerns the gene PDCD1 and melanoma.